Abstract:Objective:To investigate the effects of Calmodulin 2 on the proliferation, invasion and migration of pancreatic cancer cells.Methods:The gene expression profiling interactive analysis (GEPIA2.0) was utilized to analyze the expression difference of CALM2 gene in 179 cases of pancreatic cancer and 171 cases of paracancerous tissues in the cancer genome atlas (TCGA) and GTEx databases by using analysis of variance (ANOVA). Kaplan Meier curves were drawn in 89 cases of pancreatic cancer with high expression of CALM2 and 89 cases of pancreatic cancer with low expression of CALM2, and the prognosis was analyzed by log rank test. Human pancreatic cancer cell lines SW1990 and ASPC1 were infected with CALM2 short hairpin RNA (shRNA) lentivirus respectively and divided into control group and CALM2 knockdown group. The pancreatic cancer cell line BxPC-3 was infected with CALM2 overexpression lentivirus coated plasmids respectively and divided into vector group and CALM2 overexpression group. The expression levels of CALM2 mRNA was analyzed by real-time fluorescent quantitative polymerase chain reaction (RT-PCR) in cells after knockdown or overexpression of CALM2. The expression levels of CALM2 protein was analyzed by Western blotting in cells after knockdown or overexpression of CALM2. The cell proliferation ability was analyzed by colony formation and subcutaneous injection of tumor bearing nude mice in vivo after knockdown or overexpression of CALM2. The invasion and migration ability was analyzed by scratch test and Transwell assay in cells after knockdown or overexpression of CALM2. Results:The relative expression level of CALM2 mRNA in pancreatic cancer tissues was significantly higher than that in paracancer tissues ( P<0.05). Prognosis analysis showed that high CALM2 expression was positively correlated with poor prognosis of pancreatic cancer [overall survival, hazard ratio ( HR)=1.9, P<0.05 and disease-free survival, HR=1.8, P<0.05]. The number of colonies formed by SW1990 and ASPC1 in low expression group was significantly less than that in the control group (SW1990: 185.30±20.13 vs. 728.30±24.58, t=29.60, P<0.05; ASPC1: 168.70±13.01 vs. 551.30±35.35, t=17.60, P<0.05). The results of tumor bearing nude mice showed that the quality of low expression group was significantly less than that in the control group [SW1990: (0.635±0.085) g vs. (0.343±0.053) g, t=5.83, P<0.05; ASPC1: (0.845±0.083) g vs. (0.329±0.030) g, t=11.76, P<0.05]. The average scratch distance in low expression group was significantly lower than that in the control group [SW1990: (43.67±4.04)% vs. (68.67±4.73)%, t=6.96, P<0.05; ASPC1: (41.67±3.51)% vs. (70.33±1.53)%, t=12.96, P<0.05]. The number of migrating cells in low expression group was significantly less than that in the control group (SW1990: 206.30±27.15 vs. 480.00±23.64, t=13.17, P<0.05; ASPC1: 155.70±18.56 vs. 326.00±13.45, t=12.87, P<0.05). The number of colonies formed by BxPC3 in overexpression group was significantly greater than that in the vector group (209.30±26.63 vs. 117.70±12.74, t=5.38, P<0.05). The results of tumor bearing nude mice showed that the quality of overexpression group was significantly higher than that in the vector group [(0.478±0.044) g vs. (1.354±0.209) g, t=8.22, P<0.05]. The average scratch distance in overexpression group was significantly higher than that in the vector group [(64.67±3.06)% vs. (51.67±3.51)%, t=4.84, P<0.05]. The number of migrating cells in overexpression group was significantly greater than that in the vector group (887.00±73.55 vs. 430.00±23.64, t=10.42, P<0.05). Conclusion:CALM2 can promote the ability of proliferation, invasion and migration of pancreatic cancer cells and significantly be associated with the prognosis of pancreatic cancer.

Calpain2 Upregulation Regulates EMT-Mediated Pancreatic Cancer Metastasis Via the Wnt/β-Catenin Signaling Pathway.

Increased Expression Of Calponin 2 Is A Positive Prognostic Factor In Pancreatic Ductal Adenocarcinoma

Methyl-CpG-binding Protein 2 Drives the Furin/TGF-β1/Smad Axis to Promote Epithelial–mesenchymal Transition in Pancreatic Cancer Cells

Calpain 8 as a potential biomarker regulates the progression of pancreatic cancer via EMT and AKT/ERK pathway

Identification of a novel Calpain-2-SRC feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma

Activation of the Wnt pathway through Wnt2 promotes metastasis in pancreatic cancer.

Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.

Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel Via EGFR-pAKT Pathway

TFCP2 Activates Beta-Catenin/tcf Signaling in the Progression of Pancreatic Cancer.

Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-κB/DNMT1 signaling pathway.

Regulatory effects of Calmodulin 2 on proliferation, invasion and migration of pancreatic cancer cells

Silencing CAPN2 Expression Inhibited Castration-Resistant Prostate Cancer Cells Proliferation and Invasion Via AKT/mTOR Signal Pathway

Capn4 Promotes Epithelial-Mesenchymal Transition in Human Melanoma Cells Through Activation of the Wnt/β-catenin Pathway.

Lipocalin-2 is Associated With a Good Prognosis and Reversing Epithelial-to-Mesenchymal Transition in Pancreatic Cancer

Over-expression of ANP32E is associated with poor prognosis of pancreatic cancer and promotes cell proliferation and migration through regulating β-catenin

CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Proliferation, Invasion, and Metastasis of Pancreatic Cancer Cells

Calpain 2 Knockdown Promotes Cell Apoptosis and Restores Gefitinib Sensitivity Through Epidermal Growth Factor Receptor/protein Kinase B/survivin Signaling.

Calpain-2 As A Target For Limiting Prostate Cancer Invasion

Impact of High-Mobility-group A2 Overexpression on Epithelial-Mesenchymal Transition in Pancreatic Cancer

EPAS1 promote tumor progression by interacting with Wnt/β-catenin signaling in pancreatic cancer

NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway